Hanmi Pharmaceutical ahead of launching anti-obesity drug EPPE
For GLP-1 peptide obesity treatments such as Wegovy and Mounjaro, process optimization and yield securing during mass production are considered key factors determining commercial success. Attention is focusing on whether Hanmi Pharmaceutical's obesity drug "EPPE," which is set to launch in the second half of this year, can catch two birds with one stone—secu..